Pharmaceuticals

Global Plasma Protein Therapeutics Market Revenue and Share Analysis Through 2029

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the plasma protein therapeutics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Plasma Protein Therapeutics Market In The Period 2029-2034?

The plasma protein therapeutics market size has exhibited strong growth in recent years. This market is set to expand from $32.22 billion in 2024 to $34.68 billion in 2025, progressing at a compound annual growth rate (CAGR) of 7.6%. The expansion observed historically can be attributed to factors such as the increasing prevalence of rare diseases, a growing aging population, the global supply of blood plasma, a rise in hemophilia cases, enhancements in diagnosis, and a supportive regulatory environment.

The plasma protein therapeutics market is projected to experience robust expansion over the coming years. This market is forecast to reach $45.58 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.1%. Key drivers for this growth during the forecast period include advancements in gene therapy, a rise in healthcare spending, a broader range of indications, the adoption of precision medicine approaches, and various patient access programs. Significant trends anticipated in the forecast period encompass technological innovations, the integration of telemedicine, advancements in plasma fractionation technology, the creation of next-generation therapies, the embracing of recombinant therapies, and strategies centered around personalized medicine.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

What Strategic Drivers Are Accelerating The Plasma Protein Therapeutics Market Expansion?

The growing occurrence of autoimmune disorders is anticipated to boost the expansion of the plasma protein therapeutics market in the coming years. An autoimmune disorder is a medical state where the body’s immune system mistakenly targets and eradicates healthy body cells. Therapeutic plasma exchange serves as a treatment for autoimmune conditions, which arise when the body incorrectly identifies parts of itself as foreign, subsequently generating proteins called autoantibodies that then attack those misidentified body parts. For instance, a May 2023 study by the University of Glasgow, a UK-based public university, involving 22 million people, discovered that autoimmune disorders impact approximately 10% of the UK’s population, surpassing previous estimates. Hence, the escalating prevalence of autoimmune disorders is a key driver for the plasma protein therapeutics market’s growth moving forward.

What Is The Detailed Segment Distribution Of The Plasma Protein Therapeutics Market?

The plasma protein therapeutics market covered in this report is segmented –

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products

2) By Route Of Administration: Intravenous, Subcutaneous

3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Subsegments:

1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Albumin: Human Serum Albumin, Recombinant Albumin

3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates

4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors

5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates

How Are Global Trends Impacting The Development Of The Plasma Protein Therapeutics Market?

Product innovation is emerging as a significant trend in the plasma protein therapeutic gaining market. Leading companies operating in the plasma protein therapeutic sector are focusing on developing innovative products to gain a competitive advantage. For instance, in October 2023, Octapharma AG, a Switzerland-based company, received approval from European medical authorities for the lyophilized version of its widely recognized product, octaplasLG. This advanced formulation is designed for pre-hospital transfusion, providing healthcare professionals with a convenient and effective option for managing patients in critical situations. The approval underscores Octapharma’s commitment to enhancing patient care through innovative solutions in the field of blood products.

Who Are The Major Stakeholders Operating In The Plasma Protein Therapeutics Market?

Major companies operating in the plasma protein therapeutics market include CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., New York Blood Center, Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Australian Red Cross Lifeblood

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Plasma Protein Therapeutics Market?

North America was the largest region in the plasma protein therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9213&type=smp

Browse Through More Reports Similar to the Global Plasma Protein Therapeutics Market 2025, By The Business Research Company

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Rituximab Biosimilar Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795